609 related articles for article (PubMed ID: 28727518)
21. Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies.
Tan JY; Wijesinghe IVS; Alfarizal Kamarudin MN; Parhar I
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33557011
[TBL] [Abstract][Full Text] [Related]
22. Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.
Vaubel RA; Caron AA; Yamada S; Decker PA; Eckel Passow JE; Rodriguez FJ; Nageswara Rao AA; Lachance D; Parney I; Jenkins R; Giannini C
Brain Pathol; 2018 Mar; 28(2):172-182. PubMed ID: 28181325
[TBL] [Abstract][Full Text] [Related]
23. Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
Ahrendsen JT; Sinai C; Meredith DM; Malinowski SW; Cooney TM; Bandopadhayay P; Ligon KL; Alexandrescu S
J Neuropathol Exp Neurol; 2021 Nov; 80(11):1052–1059. PubMed ID: 34580728
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Dabrafenib for three children with brainstem BRAF
Philippe L; Maria K; Tariq A; Sofia M; Christine SM; Jean-Pierre F; Dudley RW; Sébastien P; Nada J; Valérie L
J Neurooncol; 2019 Oct; 145(1):135-141. PubMed ID: 31502039
[TBL] [Abstract][Full Text] [Related]
25. Radiomics features based on MRI predict BRAF V600E mutation in pediatric low-grade gliomas: A non-invasive method for molecular diagnosis.
Xu J; Lai M; Li S; Ye K; Li L; Hu Q; Ai R; Zhou J; Li J; Zhen J; Cai L; Shi C
Clin Neurol Neurosurg; 2022 Nov; 222():107478. PubMed ID: 36244075
[TBL] [Abstract][Full Text] [Related]
26. Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
Dasgupta T; Olow AK; Yang X; Hashizume R; Nicolaides TP; Tom M; Aoki Y; Berger MS; Weiss WA; Stalpers LJ; Prados M; James CD; Mueller S; Haas-Kogan DA
J Neurooncol; 2016 Feb; 126(3):385-93. PubMed ID: 26384810
[TBL] [Abstract][Full Text] [Related]
27. Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.
Lassaletta A; Scheinemann K; Zelcer SM; Hukin J; Wilson BA; Jabado N; Carret AS; Lafay-Cousin L; Larouche V; Hawkins CE; Pond GR; Poskitt K; Keene D; Johnston DL; Eisenstat DD; Krishnatry R; Mistry M; Arnoldo A; Ramaswamy V; Huang A; Bartels U; Tabori U; Bouffet E
J Clin Oncol; 2016 Oct; 34(29):3537-3543. PubMed ID: 27573663
[TBL] [Abstract][Full Text] [Related]
28. BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas.
Chen X; Pan C; Zhang P; Xu C; Sun Y; Yu H; Wu Y; Geng Y; Zuo P; Wu Z; Zhang J; Zhang L
J Clin Neurosci; 2017 Dec; 46():50-57. PubMed ID: 28986151
[TBL] [Abstract][Full Text] [Related]
29. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
30. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
[TBL] [Abstract][Full Text] [Related]
31. Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status.
Lindsay AJ; Rush SZ; Fenton LZ
J Neurooncol; 2014 Jun; 118(2):395-404. PubMed ID: 24792487
[TBL] [Abstract][Full Text] [Related]
32. BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis.
Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Fung KM; Hassell L
Mol Neurobiol; 2018 May; 55(5):3718-3724. PubMed ID: 28534272
[TBL] [Abstract][Full Text] [Related]
33. Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.
Bergthold G; Bandopadhayay P; Hoshida Y; Ramkissoon S; Ramkissoon L; Rich B; Maire CL; Paolella BR; Schumacher SE; Tabak B; Ferrer-Luna R; Ozek M; Sav A; Santagata S; Wen PY; Goumnerova LC; Ligon AH; Stiles C; Segal R; Golub T; Grill J; Ligon KL; Chan JA; Kieran MW; Beroukhim R
Neuro Oncol; 2015 Nov; 17(11):1486-96. PubMed ID: 25825052
[TBL] [Abstract][Full Text] [Related]
34. Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Schreck KC; Strowd RE; Nabors LB; Ellingson BM; Chang M; Tan SK; Abdullaev Z; Turakulov R; Aldape K; Danda N; Desideri S; Fisher J; Iacoboni M; Surakus T; Rudek MA; Bettegowda C; Grossman SA; Ye X
Clin Cancer Res; 2024 May; 30(10):2048-2056. PubMed ID: 38446982
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology.
Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K
Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249
[TBL] [Abstract][Full Text] [Related]
36. A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations.
Nakano Y; Yamasaki K; Sakamoto H; Matsusaka Y; Kunihiro N; Fukushima H; Inoue T; Honda-Kitahara M; Hara J; Yoshida A; Ichimura K
Brain Tumor Pathol; 2019 Oct; 36(4):162-168. PubMed ID: 31254135
[TBL] [Abstract][Full Text] [Related]
37. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G
Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545
[TBL] [Abstract][Full Text] [Related]
38. Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases.
Donson AM; Kleinschmidt-DeMasters BK; Aisner DL; Bemis LT; Birks DK; Levy JM; Smith AA; Handler MH; Foreman NK; Rush SZ
Brain Pathol; 2014 Mar; 24(2):173-83. PubMed ID: 24238153
[TBL] [Abstract][Full Text] [Related]
39. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
Raabe E; Kieran MW; Cohen KJ
Clin Cancer Res; 2013 Sep; 19(17):4553-8. PubMed ID: 23881924
[TBL] [Abstract][Full Text] [Related]
40. Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.
Dodgshun AJ; SantaCruz N; Hwang J; Ramkissoon SH; Malkin H; Bergthold G; Manley P; Chi S; MacGregor D; Goumnerova L; Sullivan M; Ligon K; Beroukhim R; Herrington B; Kieran MW; Hansford JR; Bandopadhayay P
J Neurooncol; 2016 Jun; 128(2):293-302. PubMed ID: 26994902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]